There have been 50 recent insider transactions recorded for Nuvation Bio Inc. (NUVB), including 35 buys and 13 sells. Total insider buying was valued at $60.99M and total insider selling at $5.93M.
Notable insiders with recent activity include Hung David, Wentworth Kerry, Cui Xiangmin. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — NUVB
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-27 |
Hung David |
10 Percent Owner, Officer: President and CEO |
RSU Award |
1,995,012 |
$5.91 |
$11.79M |
1,995,012 |
| 2026-02-27 |
Wentworth Kerry |
Chief Regulatory Officer |
RSU Award |
748,130 |
$5.91 |
$4.42M |
748,130 |
| 2026-02-27 |
Cui Xiangmin |
Director |
RSU Award |
74,813 |
$5.91 |
$442.14K |
74,813 |
| 2026-02-27 |
Hattersley Gary |
Chief Scientific Officer |
RSU Award |
748,130 |
$5.91 |
$4.42M |
748,130 |
| 2026-02-27 |
Markel Stacy |
Chief People Officer |
RSU Award |
748,130 |
$5.91 |
$4.42M |
748,130 |
| 2026-02-27 |
Hanley David C. |
Chief Technical Operations |
RSU Award |
748,130 |
$5.91 |
$4.42M |
748,130 |
| 2026-02-27 |
Liu Dongfang |
Chief Medical Officer |
RSU Award |
748,130 |
$5.91 |
$4.42M |
748,130 |
| 2026-02-27 |
Makunje Moses |
See Remarks |
RSU Award |
50,761 |
- |
- |
68,137 |
| 2026-02-27 |
Sjogren Colleen |
Chief Commercial Officer |
RSU Award |
748,130 |
$5.91 |
$4.42M |
748,130 |
| 2026-02-27 |
Sauvage Philippe |
Chief Financial Officer |
RSU Award |
748,130 |
$5.91 |
$4.42M |
748,130 |
| 2025-12-01 |
Liu Dongfang |
Chief Medical Officer |
Informative Sell |
150,000 |
$7.82 |
$1.17M |
18,000 |
| 2025-11-26 |
Liu Dongfang |
Chief Medical Officer |
Informative Sell |
10,000 |
$8.00 |
$80K |
18,000 |
| 2025-11-25 |
Liu Dongfang |
Chief Medical Officer |
Informative Sell |
10,000 |
$7.50 |
$75K |
18,000 |
| 2025-11-20 |
Hattersley Gary |
Chief Scientific Officer |
Informative Sell |
300,000 |
$7.23 |
$2.17M |
- |
| 2025-11-20 |
Liu Dongfang |
Chief Medical Officer |
Informative Sell |
20,000 |
$7.00 |
$140.07K |
18,000 |
| 2025-11-19 |
Liu Dongfang |
Chief Medical Officer |
Informative Sell |
15,000 |
$5.10 |
$76.55K |
18,000 |
| 2025-11-19 |
Hanley David C. |
Chief Technical Operations |
Informative Sell |
200,000 |
$7.14 |
$1.43M |
24,000 |
| 2025-11-17 |
Liu Dongfang |
Chief Medical Officer |
Informative Sell |
15,000 |
$4.77 |
$71.48K |
15,000 |
| 2025-10-27 |
Hattersley Gary |
Chief Scientific Officer |
Informative Sell |
100,000 |
$5.02 |
$502.46K |
- |
| 2025-08-11 |
Mashal Robert |
Director |
Gift (Received) |
350,001 |
$1.55 |
$542.5K |
350,001 |
| 2025-06-18 |
Markel Stacy |
Chief People Officer |
Informative Buy |
10,000 |
$1.71 |
$17.1K |
29,591 |
| 2025-06-17 |
Sauvage Philippe |
Chief Financial Officer |
Informative Buy |
4,000 |
$1.79 |
$7.16K |
9,902 |
| 2025-06-16 |
Hung David |
10 Percent Owner, Officer: President and CEO |
Informative Buy |
500,000 |
$1.79 |
$893.5K |
59,281,054 |
| 2025-06-16 |
Wentworth Kerry |
Chief Regulatory Officer |
Informative Buy |
26,000 |
$1.79 |
$46.54K |
26,000 |
| 2025-06-16 |
Sjogren Colleen |
Chief Commercial Officer |
Informative Buy |
50,000 |
$1.81 |
$90.35K |
81,000 |
| 2025-06-16 |
Sauvage Philippe |
Chief Financial Officer |
Informative Buy |
3,300 |
$1.84 |
$6.06K |
5,902 |
| 2025-05-21 |
Falberg Kathryn E |
Director |
RSU Award |
292,983 |
$2.03 |
$594.76K |
292,983 |
| 2025-05-21 |
Blickenstaff Kim D |
Director |
RSU Award |
292,983 |
$2.03 |
$594.76K |
292,983 |
| 2025-05-21 |
Vernon W Anthony |
Director |
RSU Award |
292,983 |
$2.03 |
$594.76K |
292,983 |
| 2025-05-21 |
Bazemore Robert B |
Director |
RSU Award |
292,983 |
$2.03 |
$594.76K |
292,983 |
| 2025-05-21 |
Mashal Robert |
Director |
RSU Award |
292,983 |
$2.03 |
$594.76K |
292,983 |
| 2025-05-02 |
Liu Dongfang |
Chief Medical Officer |
Informative Sell |
20,000 |
$2.50 |
$50.02K |
12,000 |
| 2025-04-07 |
Hung David |
10 Percent Owner, Officer: President and CEO |
Informative Buy |
300,000 |
$1.63 |
$487.5K |
58,781,054 |
| 2025-04-04 |
Hung David |
10 Percent Owner, Officer: President and CEO |
Informative Buy |
200,000 |
$1.66 |
$332.72K |
58,481,054 |
| 2025-04-01 |
Mashal Robert |
Director |
Informative Buy |
1,100 |
$1.67 |
$1.83K |
101,100 |
| 2025-02-28 |
Hung David |
10 Percent Owner, Officer: President and CEO |
RSU Award |
2,000,000 |
$1.97 |
$3.94M |
2,000,000 |
| 2025-02-28 |
Wentworth Kerry |
Chief Regulatory Officer |
RSU Award |
500,000 |
$1.97 |
$985K |
500,000 |
| 2025-02-28 |
Hattersley Gary |
Chief Scientific Officer |
RSU Award |
500,000 |
$1.97 |
$985K |
500,000 |
| 2025-02-28 |
Markel Stacy |
Chief People Officer |
RSU Award |
500,000 |
$1.97 |
$985K |
500,000 |
| 2025-02-28 |
Hanley David C. |
Chief Technical Operations |
RSU Award |
500,000 |
$1.97 |
$985K |
500,000 |
| 2025-02-28 |
Liu Dongfang |
Chief Medical Officer |
RSU Award |
500,000 |
$1.97 |
$985K |
500,000 |
| 2025-02-28 |
Makunje Moses |
See Remarks |
RSU Award |
250,000 |
$1.97 |
$492.5K |
250,000 |
| 2025-02-28 |
Sjogren Colleen |
Chief Commercial Officer |
RSU Award |
500,000 |
$1.97 |
$985K |
500,000 |
| 2025-02-28 |
Sauvage Philippe |
Chief Financial Officer |
RSU Award |
500,000 |
$1.97 |
$985K |
500,000 |
| 2024-11-11 |
Wang Junyuan Jerry |
CEO, Anheart Therapeutics Ltd. |
Informative Sell |
56,361 |
$2.89 |
$162.88K |
3,866,228 |
| 2024-10-08 |
Mashal Robert |
Director |
Informative Buy |
19 |
$2.20 |
$41.71 |
19 |
| 2024-10-07 |
Sauvage Philippe |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-10-07 |
Sauvage Philippe |
Chief Financial Officer |
RSU Award |
750,000 |
$2.17 |
$1.63M |
750,000 |
| 2024-09-04 |
Cui Xiangmin |
Director |
Conversion (Sell) |
128,792 |
- |
- |
- |
| 2024-09-04 |
Wang Junyuan Jerry |
CEO, Anheart Therapeutics Ltd. |
Conversion (Sell) |
16,957 |
- |
- |
- |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
